» Articles » PMID: 29581704

Targeting Histone Demethylase LSD1/KDM1a in Neurodegenerative Diseases

Overview
Journal J Exp Neurosci
Publisher Sage Publications
Specialty Neurology
Date 2018 Mar 28
PMID 29581704
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The autophagy-lysosome pathway sustains cellular homeostasis and is a protective mechanism against neurodegenerative diseases. Recent findings highlight the role of the histone demethylases LSD1/LDM1A as a pivotal regulator of autophagy process, by controlling the mTORC1 cascade, in neuroblastoma cells. LSD1 binds to the promoter region of the gene, where LSD1-mediated demethylation leads to the accumulation of repressive histone marks that maintain SESN2 expression at low levels. LSD1 depletion results in enhanced SESN2 expression and consequently mTORC1 inhibition, thereby triggering the induction of autophagy. Our study provides important insight into neuroepigenetic mechanisms regulating the autophagic process, offering additional opportunities for the development of novel therapeutic strategies in diseases associated with dysfunctional autophagy-lysosomal pathway.

Citing Articles

Gene editing improves endoplasmic reticulum-mitochondrial contacts and unfolded protein response in Friedreich's ataxia iPSC-derived neurons.

Mishra P, Sivakumar A, Johnson A, Pernaci C, Warden A, El-Hachem L Front Pharmacol. 2024; 15:1323491.

PMID: 38420191 PMC: 10899513. DOI: 10.3389/fphar.2024.1323491.


Tremendous Fidelity of Vitamin D3 in Age-related Neurological Disorders.

Skv M, Abraham S, Eshwari O, Golla K, Jhelum P, Maity S Mol Neurobiol. 2024; 61(9):7211-7238.

PMID: 38372958 DOI: 10.1007/s12035-024-03989-w.


An Updated Review on the Significance of DNA and Protein Methyltransferases and De-methylases in Human Diseases: From Molecular Mechanism to Novel Therapeutic Approaches.

Ghanbari M, Khosroshahi N, Alamdar M, Abdi A, Aghazadeh A, Feizi M Curr Med Chem. 2023; 31(23):3550-3587.

PMID: 37287285 DOI: 10.2174/0929867330666230607124803.


Lysine-Specific Demethylase 1 (LSD1)-Mediated Epigenetic Modification of Immunogenicity and Immunomodulatory Effects in Breast Cancers.

Lee D, Salahuddin T, Iqbal J Curr Oncol. 2023; 30(2):2127-2143.

PMID: 36826125 PMC: 9955398. DOI: 10.3390/curroncol30020164.


MiR-542-3p Suppresses Neuroblastoma Cell Proliferation and Invasion by Downregulation of KDM1A and ZNF346.

Wei Q, Guo Z, Chen D, Jia X Open Life Sci. 2021; 15:173-184.

PMID: 33987474 PMC: 8114778. DOI: 10.1515/biol-2020-0018.


References
1.
Pasha M, Eid A, Eid A, Gorin Y, Munusamy S . Sestrin2 as a Novel Biomarker and Therapeutic Target for Various Diseases. Oxid Med Cell Longev. 2017; 2017:3296294. PMC: 5485329. DOI: 10.1155/2017/3296294. View

2.
Laurent B, Ruitu L, Murn J, Hempel K, Ferrao R, Xiang Y . A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation. Mol Cell. 2015; 57(6):957-970. PMC: 4369399. DOI: 10.1016/j.molcel.2015.01.010. View

3.
Menzies F, Fleming A, Caricasole A, Bento C, Andrews S, Ashkenazi A . Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities. Neuron. 2017; 93(5):1015-1034. DOI: 10.1016/j.neuron.2017.01.022. View

4.
Parmigiani A, Nourbakhsh A, Ding B, Wang W, Kim Y, Akopiants K . Sestrins inhibit mTORC1 kinase activation through the GATOR complex. Cell Rep. 2014; 9(4):1281-91. PMC: 4303546. DOI: 10.1016/j.celrep.2014.10.019. View

5.
Fullgrabe J, Ghislat G, Cho D, Rubinsztein D . Transcriptional regulation of mammalian autophagy at a glance. J Cell Sci. 2016; 129(16):3059-66. DOI: 10.1242/jcs.188920. View